Introduction
Toxic psychosis is a recognized complication of antihistamine poisoning (Goodman and Gilman, 1975) . It has been suggested that this toxic state might be caused by anticholinergic mechanisms and that treatment with physostigmine could reverse it (Granacher and Baldessarini, 1975) . Despite this, physostigmine is not usually recommended in the management of antihistamine poisoning. A case is now reported of antihistamine poisoning which was complicated by marked central symptoms. These symptoms were abolished by physostigmine salicylate.
Case report
A 40-year-old housewife was admitted to the medical ward having taken an unknown number of promethazine tablets. She was deeply unconscious and responded only in a sluggish and inco-ordinated manner to pain. Her 
Discussion
The central effects of antihistamines constitute their greatest danger in acute poisoning. The presentation may vary from confusion, hallucinations and convulsions to deepening coma and respiratory arrest. Peripheral effects of poisoning include fixed dilated pupils, tachycardia, flushed skin and pyrexia (Goodman and Gilman, 1975) .
In addition to H1-receptor blocking properties, antihistamines also possess peripheral and central anticholinergic effects (Goodman and Gilman, 1975 (Granacher and Baldessarini, 1975) .
Toxic anticholinergic effects may be reversed by treatment with a suitable anticholinesterase. Physostigmine is most commonly used because in contrast to neostigmine it passes the blood-brain barrier and reverses both central and peripheral anticholinergic blockade (Duvoisin and Katz, 1968) . The value of physostigmine in atropine poisoning is well known, and more recent reports have described its role in the treatment of tricyclic antidepressant (Janson, Watt and Hermos, 1977) and phenothiazine poisoning (Wang and Marlowe, 1977 ). It appears that antihistamines, too, may produce an anticholinergic syndrome. Indeed, most if not all of the clinical features of antihistamine poisoning are attributable to anticholinergic toxicity. The reversal by physostigmine of the delirium described in the case report supports this contention. In addition, physostigmine has been shown to reverse central excitement and depression following antihistamine premedication (Lee, Turndorf and Poppers, 1975) .
Antihistamine poisoning in adults is not usually a life-threatening event, and simple supportive measures are adequate (Goodman and Gilman, 1975) . In children and more severely poisoned adults central complications are frequent, and it is here that physostigmine may play a useful role. Features of the anticholinergic syndrome such as confusion, coma and convulsions may be expected to respond (Rumack, 1973) and, in addition, peripheral anticholinergic blockade will be reversed. Because of the short half-life of physostigmine, demonstrated by the return of symptoms in the case report, repeated doses may be needed. Physostigmine should be used with caution in patients who have an underlying condition such as heart block or asthma which would contra-indicate excessive cholinergic stimulation (Granacher and Baldessarini, 1975 
